Press releases

Month Year

Email alerts

Mar 24, 2011

Medtronic Announces FDA Approval of Consulta(R) and Syncra(TM) Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems

CRT Innovation is the First to Offer Exclusive OptiVol(R) Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management

MINNEAPOLIS, Mar 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food & Drug Administration (FDA) has approved its Consulta(R) and Syncra(TM) cardiac...
Mar 16, 2011

Medtronic Announces Launch of Activa(R) SC Deep Brain Stimulation System

Single-Channel Device Completes Medtronic's Advanced Activa(R) Therapy Portfolio for Patients with Movement Disorders

MINNEAPOLIS, Mar 16, 2011 (BUSINESS WIRE) -- With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation (DBS) therapy, Medtronic, Inc. (NYSE: MDT) today announced...
Mar 14, 2011

Medtronic Announces Global Launch of New Heart Valve Repair Ring Designed to Adapt to Heart's Natural Valve

NewRemodeling Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio

MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour...
Mar 14, 2011

Medtronic Pledges $1 Million to Relief Efforts in Japan

MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it is pledging a total of $1 million (U.S.) in direct grants, employee matching grants and product...
Mar 11, 2011

Medtronic CFO Gary Ellis to Speak at Barclays Capital 2011 Global Healthcare Conference

MINNEAPOLIS, Mar 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Barclays Capital 2011...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa